Business
Press Release Jul 24 2023
Biocon Limited has informed the Exchange regarding a press release dated July 24, 2023, titled "Biocon Biologics Announces Positive CHMP Opinion for YESAFILI��, Biosimilar Aflibercept ".
About this update from Biocon Limited
[{"type":"text","content":" Biocon Limited has informed the Exchange regarding a press release dated July 24, 2023, titled \"Biocon Biologics Announces Positive CHMP Opinion for YESAFILI��, Biosimilar Aflibercept \". View Attachment","length":343,"tagName":"div"}]